Brexpiprazole HCl
CAS No. 913612-38-1
Brexpiprazole HCl ( OPC 34712 dihydrochloride )
Catalog No. M22542 CAS No. 913612-38-1
Brexpiprazole is a new antipsychotic drug.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 272 | Get Quote |
|
10MG | 408 | Get Quote |
|
25MG | 672 | Get Quote |
|
50MG | 945 | Get Quote |
|
100MG | 1278 | Get Quote |
|
500MG | 2547 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBrexpiprazole HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionBrexpiprazole is a new antipsychotic drug.
-
DescriptionBrexpiprazole is a new antipsychotic drug.
-
SynonymsOPC 34712 dihydrochloride
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number913612-38-1
-
Formula Weight433.6
-
Molecular FormulaC25H27N3O2S.xHCl
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.O=c1ccc2ccc(OCCCCN3CCN(CC3)c3cccc4sccc34)cc2[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wen-Yu Hsu , Hsien-Yuan Lane , Chieh-Hsin Lin.Brexpiprazole for the treatment of schizophrenia.Expert Opin Pharmacother. 2017 Feb;18(2):217-223.
molnova catalog
related products
-
Dihydroevocarpine
Dihydroevocarpine shows potent anti-Helicobacter pylori activity with the minimum inhibitory concentration (MIC) value of 10-20 microg/ml. Dihydroevocarpine is a moderate modulator of p-glycoprotein (p-gp) activity; it shows more potent inhibitory effects against MAO-B compared to MAO-A.
-
Bucladesine sodium s...
Bucladesine, PKA activator, is a cyclic nucleotide derivative that mimics the action of endogenous cAMP and is capable of permeating the cell membrane.
-
Phthalic Acid Monobe...
Used as organic synthesis and medicine intermediate.